Zheng, Kai
Hu, Fan
Zhou, Yang
Zhang, Juan
Zheng, Jie
Lai, Chuan
Xiong, Wan
Cui, Ke
Hu, Ya-Zhuo
Han, Zhi-Tao
Zhang, Hong-Hong
Chen, Jian-Guo
Man, Heng-Ye http://orcid.org/0000-0002-3530-3066
Liu, Dan
Lu, Youming http://orcid.org/0000-0002-6754-4411
Zhu, Ling-Qiang http://orcid.org/0000-0001-9964-9229
Funding for this research was provided by:
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (32070960)
Article History
Received: 25 June 2020
Accepted: 25 February 2021
First Online: 26 March 2021
Competing interests
: The peptide used to block the direct phosphorylation of Add1 submitted to the Patent Office of the People’s Republic of China by Dr. Ling-Qiang Zhu, Dr. Fan Hu, Dr. Dan Liu, Dr. Jie Zheng, Dr. Yang Zhou (Application No. 202011632141.7). The remaining authors declare no competing interests.